Immunocore Holdings plc
IMCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $3 | $2 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $3 | $2 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -0.7% | 72.9% | 295.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 96.6% | 99.6% | 96.3% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -15.5% | -20.7% | -26.6% | -457% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -16.5% | -22.2% | -30.1% | -493.4% |
| EPS Diluted | -1.02 | -1.13 | -0.95 | -3 |
| % Growth | 9.7% | -18.9% | 68.3% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |